Australian Super Pty LTD Bristol Myers Squibb CO Transaction History
Australian Super Pty LTD
- $17.1 Billion
- Q2 2024
A detailed history of Australian Super Pty LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Australian Super Pty LTD holds 3,857,561 shares of BMY stock, worth $188 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
3,857,561
Previous 3,081,653
25.18%
Holding current value
$188 Million
Previous $167 Million
4.14%
% of portfolio
0.94%
Previous 0.99%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,399Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.09 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.73 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.45 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.63 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.88 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...